Younger window of opportunity for HRT

HRT should be recommended for perimenopausal women and those with premature menopause, a review of current research shows.

Published  in Obstetrician & Gynaecologist, the study highlights the benefits of HRT for younger women heading into menopause and symptomatic women under 45.

Women with premature ovarian insufficiency should be strongly advised to consider taking HRT until the average menopausal age of 51.4 years, the UK authors say, noting